DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JUNE 26, 2024
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JUNE 26, 2024 Québec, QUÉBEC, June 25, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...
Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm
PRESS RELEASE For immediate release Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm Third quarter revenues increased 1,162% year over year Third quarter net loss for the quarter...
Devonian appoints André P. Boulet to Chairman of the Board and Chief Operating Officer
PRESS RELEASE For immediate release Devonian appoints André P. Boulet to Chairman of the Board and Chief Operating Officer Montreal, June 3, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical...
Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update
PRESS RELEASE For immediate release Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update Quebec, Québec, March 28, 2024. Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial...
Devonian Announces Closing of a Private Placement of Units
PRESS RELEASE For immediate release Devonian Announces Closing of a Private Placement of Units Not for distribution to United States newswire services or for dissemination in the United States QUÉBEC, March 14, 2024 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Names Kathryn J. Gregory to the Board of Directors and Grants Stock Options
PRESS RELEASE For immediate release Devonian Names Kathryn J. Gregory to the Board of Directors and Grants Stock Options QUÉBEC, February 29, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical...
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
PRESS RELEASE For immediate release Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada QUÉBEC, February 27, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF),...
Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan
PRESS RELEASE For immediate release Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan QUEBEC, February 26, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical...
Devonian Announces the Results of its Annual General and Special Shareholders’ Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options
PRESS RELEASE For immediate release Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options Not for distribution to United States newswire services or for...
DEVONIAN BOLSTERS INTELLECTUAL PROPERTY WITH ISSUANCE OF U.S. PATENT COVERING A METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE
PRESS RELEASEFor immediate release DEVONIAN BOLSTERS INTELLECTUAL PROPERTY WITH ISSUANCE OF U.S. PATENT COVERING A METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE QUÉBEC, Québec – February 20, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV:...